Slide 1: Uscom Limited 2014 Annual General Meeting
Uscom Limited 2014 Annual General Mee8ng For personal use only Wednesday 26 November 2014 Suite 1, Level 7, 10 Loftus Street, Sydney 1 www.uscom.com.au The Measure of Life
Slide 2: Agenda
Agenda For personal use only • Quorum / Open meeting • Chairman’s Welcome, Introduction of Board Members • Chairman’s Presentation • GM Operations Update • Notice of Meeting – Taken as Read • Consideration of Reports • Business – Resolutions 1 - 6 • Close of Meeting 2 www.uscom.com.au
Slide 3: Introduction
Introduction For personal use only Board of Directors: Dr Rob Phillips Ms Sheena Jack Mr Christian Bernecker Company Secretary – Ms Catherine Officer 3 www.uscom.com.au
Slide 4: Executive Chairman's Report
Executive For personal use only Chairman’s Report Dr Rob Phillips PhD(Med), MPhil(Med), FASE, DMU(Cardiol) Execu=ve Chairman, Chief Execu=ve Officer, Head Clinical Science 4 www.uscom.com.au
Slide 5: 2014 Strategy: Distribution. Sales. Revenue.
2014 Strategy For personal use only Distribution. Sales. Revenue. 5 www.uscom.com.au
Slide 6: Achievements - 2014
Achievements - 2014 For personal use only • Integrated Pulsecor assets and operations - BP+ doubled company • Appointed global sales manager • Manufactured first Uscom BP+ • Product improvements • Regulatory transfers and approvals • Manufacturing specs • Distribution – 15 new distributors (+125%) -
Slide 7: UCM – Revenue Growth
UCM – Revenue Growth For personal use only Annual Revenue $1,200,000 $1,056,619 $1,000,000 $800,000 +68% $638,734 $600,000 $400,000 $200,000 $0 2013 2014 7 “Tipping point” www.uscom.com.au
Slide 8: UCM – Distribution Growth
UCM – Distribution Growth For personal use only Distribution Agreements 40 34 35 30 +26% 27 25 +125% 20 15 12 10 5 * FY to date 0 2013 2014 2015* Growing distribution Growing revenue 2 year lag time 8 www.uscom.com.au
Slide 9: UCM – Sales Growth
UCM – Sales Growth For personal use only Quarterly Sales Revenue 400000 350000 300000 250000 200000 $ 150000 100000 50000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2013 2013 2013 2013 2014 2014 2014 2014 2015 “Tipping point” Impact of new distribution strategy Corresponding Q on Q comparison – av $120k to $300k
Slide 10: UCM – Growth Rate
UCM – Growth Rate For personal use only Quarterly Growth in Receipts 200 150 100 50 % 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2013 2013 2013 2013 2014 2014 2014 2014 2015 -50 -100 Average % growth 150-200% for Q on Q receipts for last 3 quarters “Tipping point” Impact of new distribution strategy 10 www.uscom.
Slide 11: UCM - Investment
UCM - Investment For personal use only Uscom Share Price 25 22 20 15 15 $ x 100 10 10.5 +49% pa 6.7 5 0 Jan-12 2012 vwap 2013 vwap 2014 vwap 3 year trend growth = 49% pa Unrecognised value following BP+ acquisition and sales growth Significant price re-alignment as revenue recognised Tightly held –
Slide 12: UCM – Investor Research
UCM – Investor Research For personal use only 12 Research – published 31st Mar 2014 www.uscom.com.au
Slide 13: UCM – Investor Research
UCM – Investor Research For personal use only “……. in the hot biotech sector, Uscom appears to be flying under investors' radars.” http://www.proactiveinvestors.com.au/companies/news/52663/uscoms-central-blood-pressure-device-named-as- gold-standard-for-measurement-in-global-study-52663.html Researc
Slide 14: Manufacture and Sales 2014
Manufacture and Sales For personal use only 2014 14 www.uscom.com.au
Slide 15: Australian of the Year Finalist - 2015
Australian of the Year Finalist - 2015 For personal use only Saving lives using USCOM Haemodynamics In sepsis Professor Brendan Smith 15 www.uscom.com.au
Slide 16: Biotech Company of the Year October 2014
Biotech Company of the Year For personal use only October 2014 16 www.uscom.com.au
Slide 17: Testimonial
Testimonial For personal use only “We bought our USCOM about 3 years ago, and we use it routinely to manage fluid and sepsis, and we love it; it’s changed the way we see and manage haemodynamics The physicians all use the USCOM, and many of the senior trainees. Echocardiography is difficult and inac
Slide 18: Strategy - 2015
Strategy - 2015 For personal use only Meeting the demand….. Distribution. Sales. Revenue. 18 www.uscom.com.au
Slide 19: General Manager Nick Schicht
For personal use only General Manager Nick Schicht 19 www.uscom.com.au
Slide 20: Manufacturing Strategy
Manufacturing Strategy For personal use only Three phase manufacturing growth strategy 1 Uscom – In house assembly and testing 2 Outsourced – Local purchase + manufacture 3 Outsourced – International logistics + manufacture Depends on demand and volume – shifting as required 20 www.uscom.com.au
Slide 21: Current Manufacturing
Current Manufacturing For personal use only Phase 1 • USCOM 1A and BP+ - manufactured, tested and quality controlled by Uscom • Sub assemblies are outsourced (local and international) • Build to minimal inventory • Component lead time - 2 to 15 weeks • Minimum quantity orders are delivered in drops
Slide 22: Future Manufacturing
Future Manufacturing For personal use only • Phase 2 • Local volume manufacturer • Uscom involvement in logistics • Phase 3 • High volume manufacture • Asian/European based • Full procurement • Global supply chain 22 www.uscom.com.au
Slide 23: Executive Chairman's Report Summary
For personal use only Executive Chairman’s Report Summary 23 www.uscom.com.au
Slide 24: 2015
2015 For personal use only • Maintaining momentum and growth – increased management • Expanding distributor numbers • Increasing distribution effectiveness • Bring BP+ to large volume distribution partners • Manufacturing to meet orders • Institutionalising the share register • Growing the science –
Slide 25: Risks
Risks For personal use only • Global medical markets unpredictable • Product development/regulatory slower and more costly than expected • Distribution slow to achieve revenue goals • Competitive risks and patent breaches • Supplying stock to meet orders 25 www.uscom.com.au
Slide 26: Achievements & Targets
Achievements & Targets For personal use only • Operations – Revenues from activities up 67%, and cash on hand up 292% • Growth – Successful integration of Pulsecor IP, systems and assets • Milestones – Manufacture/sale of Uscom BP+, USA BP+ patent, and CE approval 2014 • Distribution – Increased dis
Slide 27: Strategy - 2015
Strategy - 2015 For personal use only Meeting the demand….. Distribution. Sales. Revenue. 27 www.uscom.com.au
Slide 28: Questions and Discussion
Uscom Limited 2014 Annual General Mee8ng For personal use only Questions and Discussion Wednesday 26 November 2014 Suite 1, Level 7, 10 Loftus Street, Sydney www.uscom.com.au The Measure of Life